Joel Greenblatt acquired 20.1 Thousand Veracyte shares worth $626 Thousand. That's 0.01% of their equity portfolio (978th largest holding). The first Veracyte trade was made in Q2 2019. Since then Joel Greenblatt bought shares eight more times and sold shares on eight occasions. The stake costed the investor $470 Thousand, netting the investor a gain of 33% so far.